According to Lieutenant Colonel, Associate Professor, Assoc. Prof. Dr. Chu Van Men, Director of the Center for Clinical Trials and Bioequivalence, Military Medical Academy, phase 3 injected the Nano Covax vaccine to 13,000 people and administered only a single dose group injection. at least 25 mcg and the placebo injection group. Specifically, according to the protocol approved by the Ministry of Health, the first 1,000 trial injectors of the first phase of phase 3, the volunteers are injected with the ratio of “6 people vaccinated, 1 person injected placebo”. The remaining 12,000 people injected according to the ratio “2 people vaccinated, 1 person injected placebo”. It is expected that the first phase of phase 3 will be conducted by the Military Medical Academy and the Pasteur Institute in Ho Chi Minh City with 1,000 volunteers, each with 500 people. Vietnam’s first COVID-19 vaccine tested in phase 3 on humans. Regarding the reason for choosing the dose group of 25 mcg, Assoc. Prof. Dr. Chu Van Men said that testing at 3 dose levels of 25-50-75 mcg showed that the vaccine was safe on volunteers, capable of generating immunity in 3 doses. There was no difference in dose groups. Therefore, the National Ethical Council in Biomedical Research, Ministry of Health decided to only inject 1 optimal dose of 25 mcg at this stage. Phase 3 is implemented in many centers in the country: The North is deployed by the Military Medical Academy as the focal point at Military Medical Hospital 103, in collaboration with the Preventive Medicine Center of Hung Yen province to deploy locally; In the South, the Ho Chi Minh City Pasteur Institute is the focal point to deploy, in collaboration with the Preventive Medicine Centers of Long An and Tien Giang provinces to deploy locally. After the phase 1 and phase 2 trials, the Nano Covax vaccine is judged to be quite safe, so the criteria for recruiting volunteers will be relaxed more than the previous two phases. 13,000 volunteers participating in phase 3, aged 18-75 years old, only need to check their blood count and check for antibodies to the SARS-CoV-2 virus. People who have been exposed to the SARS-CoV-2 virus or already have antibodies will be excluded from the test population. As of June 11, more than 6,500 volunteers have registered to test the Nano Covax vaccine against COVID-19 phase 3. Senior Colonel, Assoc. Prof. Dr. Ho Anh Son, Deputy Director of the Military Medical and Pharmaceutical Research Institute, Military Medical Academy added: “It is expected that by mid-September 2021, after about 42 days of the second injection. In two of the first 1,000 experimental injections, we will summarize the results of the quality assessment to report. If it is favorable, we will submit the dossier and propose the Government, the Ministry of Health, and the National Ethical Council in the study. In parallel with that process, the unit will continue to test the Nano Covax vaccine on 12,000 volunteers to continue to control the experimental injection and evaluate the effectiveness. protective power of vaccines”. During the testing process and after the antibody sample is available, the Military Medical Academy will coordinate with the Nanogen Pharmaceutical Biotechnology Joint Stock Company, the testing units to conduct the assessment of the ability to neutralize the SARS-CoV virus. -2 in the laboratory for existing virus strains to determine the development direction of vaccine research in the coming period. Through discussions with the expert group of Nanogen Pharmaceutical Biotechnology Joint Stock Company, in addition to recombinant protein technology, there are other technologies for research and production of vaccines. Nanogen as well as many Vietnamese scientists are very interested in mRNA technology – which has been of great interest to the world in recent years. This technology has the advantage of reacting very quickly to the disease, quickly getting a vaccine. According to available information, vaccines produced by this technology are very safe for human use. More information about the phase 3 trial, Lieutenant General, Prof. Dr. Do Quyet, Director of the Military Medical Academy, said that this trial phase is designed according to the adaptive design method, continuing to inject the experimental vaccine. trial and placebo group; health assessment at the time of the first injection, the second dose (done on the 28th day), the 35th day and the 42nd day after injection. The Director of the Military Medical Academy expressed confidence in the safety of the Nano Covax vaccine with the results achieved through the previous two testing phases. Specifically, the concentration of SARS-CoV-2 virus antibodies after the phase 2 trial injection showed that the antibody titre increased very high, from tens to hundreds of times. After the second injection, the volunteers had a physical examination (blood test, blood pressure measurement…) once a week to assess the amount of antibodies appearing in the body; then continue to be monitored for 6 months to get information, assess health as well as immunity ability. Up to now, 100% of volunteers who have been vaccinated with Nano Covax vaccine have produced antibodies in the blood. – Phase I (December 2020), the COVID-19 vaccine Nano Covax was administered to 60 volunteers. – Phase II (February 2021) injected over 554 people. From phase 2, the trial was conducted both at the Military Medical Academy and the Medical Center of Ben Luc district – Long An province (by the Pasteur Institute in Ho Chi Minh City).

Illustration GS. Dr. Truong Viet Dung, Chairman of the National Ethics Council in Biomedical Research, said in the SK & DS newspaper, in phase 3, the subjects of the Nano Covax vaccine trial in Vietnam will expand. The object here means the area, which can be extended to other areas such as workers in industrial zones. However, areas or industrial zones with COVID-19 cases were not selected for clinical trials because it would be interpreted as the epidemic situation that made people too worried and accepted to participate in the research. Therefore, research can only be carried out in industrial zones at risk of disease outbreaks, not in industrial zones with epidemics. Testing participants for COVID-19 to confirm the absence of antibodies is required. In the spirit of “testing as quickly as possible” of the Government, the Ministry of Health assigned testing units. Fast does not mean cutting, skipping stages. Any stage must comply with international requirements and standards. Do it very quickly but must be very standard, giving it to the Council must be approved immediately. In general, in accordance with the process and step by step of each phase, so that the Ministry of Health has enough scientific basis to be able to grant urgent and conditional use of Nano Covax vaccine in Vietnam. Information on Vietnam plus, Deputy Director of Military Medical Research Institute Ho Anh Son said that according to the latest information, it is possible that as soon as next week (expected in early June 2021) will enter vaccine research. Nano Covax phase 3 with the expected number of volunteers to participate is about 13,000 people. In phase 3, the implementation is very fast, following the correct process, and at the same time meeting the needs of disease control in Vietnam. Up to now, the Military Medical Academy has mobilized a lot of doctors, technicians, students… to participate in the testing process so that it can be ready for deployment in 10 provinces/cities across the country at the same time. country. After testing phase 1 and phase 2, Nano Covax vaccine is quite safe, so the criteria for recruiting volunteers will be relaxed more than the previous 2 phases. Volunteers participating in phase 3 from 18-75 years old, only need to check the blood count and check for antibodies to the SARS-CoV-2 virus. People who have been exposed to the SARS-CoV-2 virus or already have antibodies will be excluded from the test population. More about the phase 3 trial, Lieutenant General, Professor-Dr. Do Quyet, Director of the Military Medical Academy, Ministry of National Defense said that he believes in the safety of the Nano Covax vaccine with the results achieved. through the previous two phases of testing. According to the Director of the Military Medical Academy, immunogenicity is reflected in two main factors: antibody concentration and antibody immunogenicity. Specifically, the concentration of SARS-CoV-2 virus antibodies after injection of the phase 2 trial showed a very high increase in antibody titres, from tens to hundreds of times. Antibody immunogenicity to assess the ability to neutralize SARS-CoV-2 virus living at the 35th day of good response, above the prescribed threshold. As for the ability to neutralize the virus at day 42, the team has now evaluated 22/110 samples; expected to be completed in early June 2021 to report to the National Ethics Council in Biomedical Research. Phase 3 aims to evaluate the protective effect of the vaccine on the community, designed in many centers, expanding to other localities with a larger number of samples with only 1 injection. Based on the results of the evaluation, the National Ethical Council in Biomedical Research selected the experimental injection of 25mcg dose. Strictly following international guidelines, the National Ethical Council for Biomedical Research also identified a phase 3 trial in 10,000 people. Military Medical Academy complies with the approved outline and deploys to recruit volunteers.

On May 12, at the Ministry of Health, Prof. Dr. Tran Van Thuan, Deputy Minister of Health, received 10,000 tests for SARS-CoV-2 test for epidemic prevention and control, awarded by Ampharco USA Pharmaceutical Joint Stock Company. donate. Facing the complicated situation of the Covid-19 epidemic from the end of April 2021 until now, Vietnam has recorded many domestic cases in 26 provinces and cities and hospitals, the Vietnam Young Physicians Association. requested the Ministry of Health to receive 10,000 SARV-COV-2 test kits produced and donated by Amharco USA Pharmaceutical Joint Stock Company, in order to support the strengthening of testing capacity for Covid-19 epidemic prevention and control. Speaking at the reception ceremony, Prof. Dr. Tran Van Thuan, Deputy Minister of Health, welcomed the fact that Ampharco USA Pharmaceutical Joint Stock Company used technology transferred from the Military Medical Academy to research and produce the kit. test “made in Vietnam”. The Deputy Minister said that in the face of the situation that the Covid-19 epidemic continues to affect all aspects of economic and social life, it is very meaningful for Amphaco USA to accompany the health sector to support 10,000 test kits. demonstrating the company’s social responsibility in joining hands to fight the pandemic. This is also the Government’s policy in encouraging scientists to research and produce SARS-CoV-2 diagnostic test products and products, actively contributing to the prevention and control of the Covid-19 epidemic. 19. Le Ngoc Bo – Vice Chairman of the Board of Directors of Ampharco USA Pharmaceutical Joint Stock Company said that the Covid-19 test kit “AmphaBio HT- Hithroughput PCR Covid-19” is a product developed by Amphaco USA Pharmaceutical Joint Stock Company. Research and development, according to technology transferred from the Military Medical Academy, can detect most strains of the SARS-CoV-2 virus up to now. This kit has been licensed for circulation by the Ministry of Health in Decision No. 2263/QD-BYT dated May 7, 2021. During the research and production process, the kit has been tested and clinically proven on over 2,000 patient samples. Prof. Dr. Do Quyet, Director of the Military Medical Academy, said that the AmphaBio HT- Hithroughput PCR Covid-19 test kit is a cooperation product between the Military Medical Academy and Ampharco USA, applying new technologies from the United States. . Military Medical Academy always creates the best conditions for its scientists to research and develop products of high and timely application in the prevention and control of the Covid-19 epidemic. In order to ensure the storage conditions of the above 10,000 tests, the Ministry of Health requests the Company to support the storage and preservation of the test numbers that have supported the above epidemic prevention and control at the Company’s storage warehouse. Based on the epidemic situation and proposals of units and localities; The Ministry of Health will make a decision to allocate the above test numbers to medical facilities to serve the prevention and control of the Covid-19 epidemic. Based on the allocation decision of the Ministry of Health, request the company to support the transportation and handover of testing to units and localities in a timely manner according to regulations.

Leaders of the Ministry of Health received 10,000 Covid-19 test kits. Photo: Nguyen Nhien. Facing the complicated situation of the Covid-19 epidemic from the end of April 2021 to the present, Vietnam has recorded many domestic cases in 26 provinces and cities and hospitals, the Vietnam Young Physicians Association. requested the Ministry of Health to receive 10,000 SARV-COV-2 test kits produced and donated by Amharco USA Pharmaceutical Joint Stock Company, in order to support the strengthening of testing capacity for Covid-19 epidemic prevention and control. Speaking at the reception ceremony, Prof. Dr. Tran Van Thuan – Deputy Minister of Health welcomed the fact that Ampharco USA Pharmaceutical Joint Stock Company used technology transferred from the Military Medical Academy to research and produce the kit. test “made in Vietnam”. Deputy Minister Tran Van Thuan emphasized that, with the Covid-19 epidemic continuing to affect all aspects of socio-economic life, it is a very worthwhile job for Amharco USA to accompany the health sector to support 10,000 test kits. meaningful, demonstrating the company’s social responsibility in joining hands to fight the pandemic. This is also the Government’s policy in encouraging scientists to research and produce SARS-CoV-2 diagnostic test products and products, actively contributing to the prevention and control of the Covid-19 epidemic. 19. Le Ngoc Bo – Vice Chairman of the Board of Directors of Ampharco USA Pharmaceutical Joint Stock Company said that the Covid-19 test kit “AmphaBio HT- Hithroughput PCR Covid-19” is a product invested by Amphaco USA Pharmaceutical Joint Stock Company. , developed according to technology transferred from the Military Medical Academy, can detect most strains of the SARS-CoV-2 virus so far. This kit has been licensed for circulation by the Ministry of Health in Decision No. 2263/QD-BYT dated May 7, 2021. During the research and production process, the kit has been tested and clinically proven on over 2,000 patient samples and is the result of more than a year of continuous efforts of the team of scientists, the partners of the Company. Ampharco USA Pharmaceutical Joint Stock Company, in order to promptly respond to the Government’s policy of “fighting the epidemic like fighting the enemy”, contributing to Vietnam’s fight against the Covid-19 epidemic. According to Prof. Dr. Do Quyet – Director of the Military Medical Academy, the AmphaBio HT – Hithroughput PCR Covid-19 test kit is a product of cooperation between the Military Medical Academy and Ampharco USA, applying new US technologies. . Military Medical Academy always creates the best conditions for its scientists to research and develop products of high and timely application in the prevention and control of the Covid-19 epidemic.

Leaders of the Ministry of Health emphasized: “In the face of the COVID-19 epidemic continuing to affect all aspects of socio-economic life, the fact that Ampharco USA accompanying the Health sector to support 10,000 test kits is a very job. makes sense, demonstrates the company’s social responsibility in joining hands to repel pandemic. This is also a policy of the Government to encourage scientists to research and manufacture products and biologicals for SARS-CoV-2 diagnostic tests, actively contributing to the prevention and control of COVID- 19 ”. The ceremony of giving away 10,000 test kits of COVID-19 “made in Vietnam”. Test kit COVID-19 “AmphaBio HT- Hithroughput PCR COVID-19” is a product invested by Ampharco USA Pharmaceutical Joint Stock Company, research and development, according to technology transferred from Military Medical Academy, yes detected most of the strains of SARS-CoV-2 virus up to now. This kit has been licensed by the Ministry of Health to circulate in Decision No. 2263 / QD-BYT dated 7/5/2021. During the research and production process, the kit has been tested and clinically proven on 2,000 patient samples. This is the result of more than a year of continuous efforts of the team of scientists and partners of Ampharco USA Pharmaceutical Joint Stock Company to promptly respond to the Government’s policy of “anti-epidemic like anti-enemy”. . Director of Military Medical Academy – Lieutenant General, Prof. Dr. Do Quyet assessed that the AmphaBio HT- Hithroughput PCR COVID-19 test kit is a product of cooperation between Military Medical Academy and Ampharco USA, applying new technologies of the United States. Military Medical Academy always creates the best conditions for the academy’s scientists to research and develop highly applied products, to promptly use them effectively in the prevention and control of COVID-19 epidemics. To ensure the preservation conditions of the 10,000 tests mentioned above, the Ministry of Health has also asked the Company to assist with storage and preservation. Based on the situation of epidemic developments and recommendations of units and localities, the Ministry of Health will decide to allocate the above test numbers to medical facilities to serve the COVID-19 epidemic prevention and control. . Based on the allocation decision of the Ministry of Health, the Company is requested to assist in transporting and handing over testing to units and localities promptly according to regulations./.

Deputy Minister of Health Tran Van Thuan received 10,000 test kits for SARS-CoV-2 On May 12, Prof.Dr. Tran Van Thuan, Deputy Minister of Health, has received 10,000 SARS-CoV-2 test kits for epidemic prevention, awarded by Ampharco USA Pharmaceutical Joint Stock Company. Facing the complicated situation of Covid-19 epidemic in the period from the end of April 2021 up to now, Vietnam has recorded many cases in the country in 26 provinces, cities and hospitals, Vietnam Young Physician Association. has proposed to the Ministry of Health to receive 10,000 test kits for SARV-COV-2 produced and awarded by Ampharco USA Pharmaceutical Joint Stock Company to support capacity building for Covid-19 epidemic prevention and control. Speaking at the reception, Prof.Dr. Tran Van Thuan, Deputy Minister of Health emphasized: “In the face of the Covid-19 epidemic continuing to affect all aspects of socio-economic life, the fact that Ampharco USA, together with the health sector, supports 10,000 test kits. a very meaningful job, demonstrating the company’s social responsibility in joining hands to repel the pandemic. This is also a policy of the Government to encourage scientists to research and produce products and biologicals for diagnostic tests for SARS-CoV-2, actively contributing to the prevention and control of Covid- 19 ”. This kit has been licensed by the Ministry of Health to circulate in Decision No. 2263 / QD-BYT dated 7/5. During the research and production process, the kit has been tested and clinically proven over 2,000 patient samples and is the result of more than a year of continuous efforts of the team of scientists and partners of the Company. Ampharco USA Pharmaceutical Joint Stock Company, in order to promptly respond to the Government’s policy of “anti-epidemic like anti-enemy”, contributes to Vietnam’s anti-epidemic Covid-19. Prof.Dr. Do Quyet, Director of Military Medical Academy, said that the AmphaBio HT-Hithroughput PCR Covid-19 test kit is a product of cooperation between the Military Medical Academy and Ampharco USA, applying new technologies of the United States. Military Medical Academy always creates the best conditions for its scientists to research and develop highly applied products, to promptly use them effectively in Covid-19 epidemic prevention and control. Following the direction of the Prime Minister, right from March 2020, the Ministry of Health established a Committee for Mobilization and Coordination of Supporting Resources for Covid-19 epidemic prevention and control (Decision No. 1219 / QD-BYT dated 19 / 3/2020 of the Minister of Health). The Ministry of Health agreed to receive 10,000 test kits for SARS-CoV-2 awarded by Ampharco USA Pharmaceutical Joint Stock Company. However, in order to ensure the storage conditions of the 10,000 test kits mentioned above, the Ministry of Health requests the company to assist in storing and preserving the test numbers that have supported the prevention of the above epidemic at the public warehouse. ty.

Deputy Minister of Health emphasized: “In the face of the COVID-19 epidemic continuing to affect all aspects of social and economic life, the Ampharco USA accompanying the Health sector to support 10,000 test kits is a job. It is very meaningful, demonstrating the company’s social responsibility in joining hands to repel pandemic. This is also a policy of the Government to encourage scientists to research and manufacture products and biologicals for SARS-CoV-2 diagnostic tests, actively contributing to the prevention and control of COVID- 19 ”. The AmphaBio HT- Hithroughput PCR COVID-19 kit can detect most of the strains of the SARS-CoV-2 virus to date. This kit has been licensed by the Ministry of Health to circulate in Decision No. 2263 / QD-BYT dated 7/5/2021. During the research and production process, the kit has been tested and clinically proven on 2,000 patient samples. Professor, Dr. Do Quyet, Director of Military Medical Academy, said that the AmphaBio HT- Hithroughput PCR COVID-19 test kit is a product of cooperation between Military Medical Academy and Ampharco USA, applying new technologies of USA. Military Medical Academy always creates the most optimal conditions for the academy’s scientists to research and develop highly and timely applied products in COVID-19 epidemic prevention and control. Following the direction of the Prime Minister, right from March 2020, the Ministry of Health has established a Committee to advocate and coordinate the COVID-19 epidemic prevention and control support. The Ministry of Health agreed to receive 10,000 test kits for SARS-CoV-2 awarded by Ampharco USA Pharmaceutical Joint Stock Company.
However, in order to ensure the storage conditions of the 10,000 test tests mentioned above, the Ministry of Health requested the Company to assist in storing and preserving the above-mentioned kits that supported the prevention of the above epidemic at the preservation warehouse of the Company. ty. Based on the situation of epidemic developments and recommendations of units and localities, the Ministry of Health will decide to allocate the above test kits to medical facilities to serve the COVID-19 epidemic prevention and control. . Based on the allocation decision of the Ministry of Health, the Company supports to transport and hand over the testing kit to units and localities promptly according to regulations.

The Ministry of Health received 10,000 Covid-19 test kits to support epidemic prevention and control. Photo: Nguyen Nhien (Office of the Ministry of Health). Faced with complicated developments in the Covid-19 epidemic since the end of April 2021 up to now, Vietnam has recorded many domestic cases in 26 provinces, cities and hospitals. The Vietnam Young Physician Association has asked the Ministry of Health to receive 10,000 SARS-COV-2 test kits produced and awarded by Ampharco USA Pharmaceutical Joint Stock Company, to support strengthening capacity for prevention and control. Covid-19 translation. At the reception, Prof. Dr. Tran Van Thuan – Deputy Minister of Health welcomed Ampharco USA Pharmaceutical Joint Stock Company used technology transferred from Military Medical Academy to research and produce the test kit. experience “made in Vietnam”. “In the face of the Covid-19 epidemic that continues to affect all aspects of socio-economic life, the fact that Ampharco USA accompanying the health sector to support 10,000 test kits is a very meaningful job, showing responsibility. Company society in joining hands to repel pandemic. This is also a policy of the Government to encourage scientists to research and produce products and biologicals for diagnostic testing for SARS-COV-2, actively contributing to the prevention and control of Covid- 19 ”- Deputy Minister of Health emphasized. Vice Chairman of the Board of Directors of Ampharco USA Pharmaceutical Joint Stock Company Le Ngoc Bo said that the Covid-19 test kit “AmphaBio HT- Hithroughput PCR Covid-19” is a product invested by Ampharco USA Pharmaceutical Joint Stock Company, Research and development, according to technology transferred from the Military Medical Academy, can detect most of the strains of the virus SARS-CoV-2 up to now. This kit has been licensed by the Ministry of Health to circulate in Decision No. 2263 / QD-BYT dated 7/5/2021. During the research and production process, the kit has been tested and clinically proven over 2,000 patient samples and is the result of more than a year of continuous efforts of the team of scientists and partners of the Company. Ampharco USA Pharmaceutical Joint Stock Company, in order to promptly respond to the Government’s policy of “anti-epidemic like anti-enemy”, contributes to Vietnam’s anti-epidemic Covid-19. Prof. Dr. Tran Van Thuan – Deputy Minister of Health welcomes Ampharco USA Pharmaceutical Joint Stock Company to use technology transferred from Military Medical Academy to research and produce “made in Vietnam” test kit. . Photo: Nguyen Nhien (Office of the Ministry of Health). Prof. Dr. Do Quyet – Director of Military Medical Academy said, AmphaBio HT- Hithroughput PCR Covid-19 test kit is a product of cooperation between Military Medical Academy and Ampharco USA, applying new technologies of the United States. . Military Medical Academy always creates the best conditions for its scientists to research and develop timely and highly applied products in Covid-19 epidemic prevention and control. Following the direction of the Prime Minister, right from March 2020, the Ministry of Health established a Committee for the mobilization and coordination of sources of support for Covid-19 epidemic prevention. The Ministry of Health agreed to receive 10,000 test tests for SARS-COV-2 awarded by Ampharco USA Pharmaceutical Joint Stock Company. However, in order to ensure the storage conditions of the 10,000 test tests mentioned above, the Ministry of Health requests that the company assist with the storage and preservation of the test numbers that have supported the prevention of the above epidemic at the public warehouse. ty. Based on the situation of epidemic developments and recommendations of units and localities, the Ministry of Health will decide to allocate the above test numbers to medical facilities to serve the Covid-19 epidemic prevention and control. . Based on the allocation decision of the Ministry of Health, the Company is requested to assist in transporting and handing over testing to units and localities promptly according to regulations.

The COVID-19 test kit is researched and developed, according to the technology transferred from the Military Medical Academy, which can detect most of the strains of the SARS-CoV-2 virus up to now. This kit has been licensed by the Ministry of Health to circulate in Decision No. 2263 / QD-BYT dated 7/5/2021. During the research and production process, the kit has been tested and clinically proven on 2,000 patient samples. Prof.Dr. Tran Van Thuan – Deputy Minister of Health. Photo: Tuan Anh. Speaking at the Reception Ceremony, Prof.Dr. Tran Van Thuan – Deputy Minister of Health welcomed the product “made in Vietnam” and emphasized: “In the face of the COVID-19 epidemic continuing to affect all aspects of socio-economic life, Ampharco USA’s accompanying Health sector is a very meaningful job, demonstrating the social responsibility in joining hands to repel the epidemic. The Ministry of Health praised the impulsive spirit of the Vietnam Young Physicians Association and believed in the wisdom, gesture and heart of the team of Vietnamese medical doctors, scientists, and the consensus of enterprises, co. For the whole country, Vietnam will defeat COVID-19 ”. The Ministry of Health received 10,000 COVID-19 test kits to support epidemic prevention. Photo: Tuan Anh. Prof.Dr. Do Quyet – Director of Military Medical Academy said, AmphaBio HT-Hithroughput PCR COVID-19 test kit is a product of cooperation between Military Medical Academy and Ampharco USA, applying new technologies of the United States. Military Medical Academy always creates optimal conditions for the academy’s scientists to research and develop timely and highly applied products in COVID-19 epidemic prevention and control. Following the direction of the Prime Minister, right from March 2020, the Ministry of Health has established a Committee for Mobilization and Coordination of the COVID-19 epidemic prevention and control support (Decision No. 1219 / QD-BYT dated 19 / 3/2020 of the Minister of Health). The Ministry of Health agreed to receive 10,000 test tests for SARS-CoV-2 awarded this time. However, to ensure the storage conditions of 10,000 tests mentioned above; The Ministry of Health requested the Company to support the storage and preservation of the test numbers that supported the prevention of the above epidemic in the Company’s repository. Based on the epidemic developments and proposals of units and localities; The Ministry of Health will decide to allocate the above test numbers to medical facilities to serve the COVID-19 epidemic prevention and control. Based on the allocation decision of the Ministry of Health, the Company is requested to assist in transporting and handing over testing to units and localities promptly.